Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Real-world data regarding indications for use of insulin pump remain sparse. We investigated characteristics among individuals with type 1 diabetes (T1D) in relation to indication for use of insulin pump (CSII). Comparison was made with T1D subjects using multiple daily injections (MDI). Methods: We included all individuals with T1D who had at least 1 registration in the National Diabetes Register during 2014-2015. Among 46 874 individuals, we excluded 2350 due to missing data. We examined 35 725 on MDI and 8799 on CSII regarding characteristics in relation to insulin delivery method, as well as association between insulin delivery and glycemic control (HbA1c) and presence of albuminuria. Results: Unadjusted mean (SD) HbA1c was 63.84 (15.07) mmol/mol (7.99 [1.38]%) and 63.75 (13.19) mmol/mol (7.99 [1.21]%) in the MDI and CSII group, respectively. MDI and CSII users were on average 48.8 and 41.5 years old, respectively. MDI users were on average 26 years old and CSII users 17 years old at the time of diabetes diagnosis. Overall, a higher proportion of CSII users were females (53.5%). As compared with MDI, use of CSII was associated with up to 7.84 mmol/mol (0.72%) lower HbA1c in a multivariable adjusted model. Use of CSII was, however, not associated with risk of having albuminuria. Conclusions: CSII was used more frequently in younger individuals, early-onset diabetes, and problematic glycemic control. The use of CSII was associated with lower HbA1c among CSII users except from those who started CSII due to high HbA1c.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The ASA Statement on p -Values: Context, Process, and Purpose
Wasserstein, R. L., & Lazar, N. A. (2016) · The American Statistician · doi:10.1080/00031305.2016.1154108 · Cited by 6,306 · cited 14×
“Indeed, this study shows that the vast majority of CSII users have started treatment due to problems with glycemic control and patients who are older (and consequently at higher risk of cardiovascular and adverse outcomes) are less frequently treated with CSII.”
MethodInfluentialPatterson, C. C., Dahlquist, G. G., Gyürüs, E., Green, A., & Soltész, G. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60568-7 · Cited by 1,854
Glycemic Control and Excess Mortality in Type 1 Diabetes
Lind, M., Svensson, A.-M., Kosiborod, M., Gudbjörnsdottir, S., Pivodic, A., Wedel, H., Dahlqvist, S., Clements, M., & Rosengren, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408214 · Cited by 964
Yeh, H.-C., Brown, T. T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y. D., Wilson, L. M., Haberl, E. B., Brick, J., Bass, E. B., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-5-201209040-00508 · Cited by 493 · cited 1×
“There are numerous long-term studies that have consistently indicated that the use of ambulatory insulin infusion pumps systems is associated with improved overall glycemic control as evidenced by lower HbA1c values without any increased risk of hypoglycemia or hyperglycemia.(7,13,14) The landmark Diabetes Control and…”
BackgroundMcKnight, J. A., Wild, S. H., Lamb, M. J. E., Cooper, M. N., Jones, T. W., Davis, E. A., Hofer, S., Fritsch, M., Schober, E., Svensson, J., et al. (2015) · Diabetic Medicine · doi:10.1111/dme.12676 · Cited by 343 · cited 1×
“Despite a high T1D diabetes burden, Sweden has a high standard of care for the type 1 population.(6) The Swedish National Diabetes Register (NDR) offers an excellent opportunity to study individuals with T1D; 95% of all individuals with T1D have been entered in the register, which includes detailed clinical data colle…”
BackgroundSelf-citationInsulin-pump therapy for type 1 diabetes mellitus
Pickup, J. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmct1113948 · Cited by 270
(2015) · doi:10.1136/bmj.h3234 · Cited by 258
Self-citation
Cited by
Jendle, J., & Reznik, Y. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15087 · Cited by 26
Self-citationMeunier, L., Aguadé, A.-S., Videau, Y., Verboux, D., Fagot-Campagna, A., Gastaldi-Menager, C., & Amadou, C. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0112 · Cited by 22
Kampmann, U., Madsen, L. R., Bjerg, L., Witte, D. R., Hasselstrøm, K., Østergård, T., Alstrup, K., Møller, M. K., Dylmer, D., & Hansen, K. W. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.04.042 · Cited by 19
Song, C., Booth, G. L., Perkins, B. A., & Weisman, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002371 · Cited by 12
Kwa, T., Zhang, G., Shepard, K., Wherry, K., & Chattaraj, S. (2021) · Journal of Medical Economics · doi:10.1080/13696998.2021.1945784 · Cited by 11
Metadata
- Authors
- Jendle, J. H., Rawshani, A., Svensson, A.-M., Avdic, T., & Gudbjörnsdóttir, S.
- Venue
- Journal of Diabetes Science and Technology
- Publisher
- SAGE Publications
- Published
- 2016-07-09
- Volume
- 10
- Issue
- 5
- Pages
- 1027-1033
- ISSN
- 1932-2968 (ISSN-L)
- OpenAlex
- W2408126433
- Cited by
- 17
- References
- 7
- FWCI
- 1.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control. https://app.cochat.ai/papers/10.1177/1932296816650209
- The paper
- Jendle, J. H., Rawshani, A., Svensson, A.-M., Avdic, T., & Gudbjörnsdóttir, S. (2016). Indications for Insulin Pump Therapy in Type 1 Diabetes and Associations With Glycemic Control. Journal of Diabetes Science and Technology. https://doi.org/10.1177/1932296816650209
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.